Infectious Diseases (except HIV/AIDS)
Showing page 190 of 716 pages of list content
-
Safety and Immunogenicity of a 100 μg mRNA-1273 Vaccine Booster for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
This article's authors -
Severity of SARS-CoV-2 Infection in Pregnancy in Ontario: A Matched Cohort Analysis
This article's authors -
Protective antibodies and T cell responses to Omicron variant three months after the booster dose of BNT162b2 vaccine
This article's authors -
Testing Frequency Matters | An Evaluation of the Diagnostic Performance of a SARS-CoV-2 Rapid Antigen Test in United States Correctional Facilities
This article's authors -
SARS-CoV-2 Omicron Variant Infection of Individuals with High Titer Neutralizing Antibodies Post-3 rd mRNA Vaccine Dose
This article's authors -
SARS-CoV-2 Seroprevalence among health care workers after the first and second pandemic wave
This article's authors -
Development of a COVID-19 risk-assessment model for participants at an outdoor music festival: Evaluation of the validity and control measure effectiveness
This article's authors -
Different forms of superspreading lead to different outcomes: heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2
This article's authors -
Immunogenicity and Safety of Booster Dose of S-268019-b or Tozinameran in Japanese Participants: An Interim Report of Phase 2/3, Randomized, Observer-Blinded, Noninferiority Study
This article's authors -
Spike mutations of the SARS-CoV-2 Omicron: more likely to occur in the epitopes
This article's authors